MindWalk Holdings Corp.

HYFT·NasdaqCM·Healthcare
Compare
1.0400−0.0600 (−5.45%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
After hours1.0700+0.0300 (+2.88%)Nov 4, 6:47 PM EST

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1.1000
Open1.1900
Day range1.01001.1900
52-week range0.99002.9900
Off day high−12.61%
Off 52-week high−65.22%
Volume1.25M
Avg. volume (3M)213.40K
Market cap49.48M
EPS (TTM)-0.2600
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.78
Shares outstanding47.57M
Short interest2.16% of float
Earnings dateSep 14, 2026 (est.)
Analyst target4.3333
Profit margin−105.20%

Against its peers

Compare in full ›
HYFT CGTX NSB.AX NPAU.F FLNA IGC
Market cap 49.48M 64.98M 21.04M 84.05M 27.63M 20.16M
P/E (TTM) — — — — — —
Forward P/E — -3.1 — — — -2.4
Price/book 9.9 2.0 1.4 -3.3 0.4 3.3
Dividend yield — — — — — —
1-year change −39.23% −58.86% −65.52% +329.03% −80.74% −48.72%
Today −5.45% −2.32% 0.00% +2.26% −3.75% +4.84%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

Latest news

All HYFT news ›
Markets Daily·Positive

Analyzing MindWalk (NASDAQ:HYFT) and Waters (NYSE:WAT)

Posted by Sarita Garza on Nov 1st, 2026 Waters (NYSE:WAT – Get Free Report) and MindWalk (NASDAQ:HYFT – Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two companies based on the…

Star Tribune·

MindWalk's Preclinical Dengue Data Support a HYFT® Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotypes, Reproduced Across Two Independent Campaigns

The Market: An Unsolved Pan-Serotype Problem in a High-Burden Infectious Disease Identifying that position requires operating below the level of sequence homology. Serotype-to-serotype sequence identity across dengue envelope domain III…

Stock Titan·Positive

MindWalk appoints Maben and Lim to development roles

MindWalk says the expanded leadership will support evaluation of pipeline programs and external opportunities as preclinical efficacy data emerge. REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES…

@StockTitan_net·Negative

MindWalk outlines ReefIQ, available since June 2026

Netlist and Micron Enter Patent License and Settlement Agreements MindWalk says failed discovery programs become queryable context for later programs, with historical and ongoing work held in one frame. MindWalk says ReefIQ enriches client…

From the 4Search news index, newest first.

In the news

7mentions in 30 days
7with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance